aluates Reports

$ 0.0

Automative

Global Artificial Organs and Bionics Market Research Report 2026

Published Date: 2026-03-31

Report Code: QYRE-Auto-8Y8056

Global Artificial Organs and Bionics Market Insights and Forecast to 2028

BUY CHAPTERS

Global Artificial Organs and Bionics Market Research Report 2026

Code: QYRE-Auto-8Y8056

Report

2026-03-31

Pages:157

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sonova

Medtronic Inc

Cochlear Ltd

SynCardia

Fresenius Medical Care

Abiomed Inc

Abbott

Baxter

B. Braun

Asahi Kasei Corporation

Nipro

MED-EL

Toray Medical

Getinge (Maquet)

William Demant

LivaNova (Sorin)

Terumo

Hangzhou Nurotron

CorWave

Listent Medical

Evaheart

Open Bionics

OYMotion Technologies

Mobius Bionics

Artificial Organs and Bionics Market Size

The global Artificial Organs and Bionics market was valued at US$ 11180 million in 2025 and is anticipated to reach US$ 18290 million by 2032, at a CAGR of 7.4% from 2026 to 2032.

Artificial Organs and Bionics Market

An artificial organ is a human made organ device or tissue that is implanted or integrated into a human — interfacing with living tissue — to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. Bionic implants refer to electronic or mechatronic parts that augment or restore physical functionality to a differently-abled person.

North America is the largest market of Artificial Organs And Bionic Implants, with a share about 45%, followed by Europe and China, both have a share about 50 percent. Global top 5 companies include Fresenius Medical Care, Cochlear, Abiomed, ABBOTT and Baxter, they hold a share over 50%.

This report delivers a comprehensive overview of the global Artificial Organs and Bionics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Artificial Organs and Bionics. The Artificial Organs and Bionics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Artificial Organs and Bionics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Artificial Organs and Bionics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Artificial Organs and Bionics Market Report

Report Metric	Details
Report Name	Artificial Organs and Bionics Market
Accounted market size in 2025	US$ 11180 million
Forecasted market size in 2032	US$ 18290 million
CAGR	7.4%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Artificial Kidney Artificial Heart & Ventricular Assist Device Cochlear Implant Artificial Lung Artificial Liver Artificial Pancreas Bionic Hands & Prosthetics Others
Segment by Application	Commercialize Clinical Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Fresenius Medical Care, Cochlear, Abiomed, ABBOTT, Baxter, B.Braun, Asahi Kasei Corporation, Nipro, MED-EL, Toray Medical, Sonova, Medtronic, Getinge (Maquet), William Demant, LivaNova (Sorin), Terumo, Hangzhou Nurotron, Syncardia, CorWave, Listent Medical, Evaheart, Open Bionics, OYMotion Technologies, Mobius Bionics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Artificial Organs and Bionics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Artificial Organs and Bionics Market growing?

Ans: The Artificial Organs and Bionics Market witnessing a CAGR of 7.4% during the forecast period 2026-2032.

What is the Artificial Organs and Bionics Market size in 2032?

Ans: The Artificial Organs and Bionics Market size in 2032 will be US$ 18290 million.

What is the market share of major companies in Artificial Organs and Bionics Market?

Ans: Global top 5 companies include Fresenius Medical Care, Cochlear, Abiomed, ABBOTT and Baxter, they hold a share over 50%.

Who are the main players in the Artificial Organs and Bionics Market report?

Ans: The main players in the Artificial Organs and Bionics Market are Fresenius Medical Care, Cochlear, Abiomed, ABBOTT, Baxter, B.Braun, Asahi Kasei Corporation, Nipro, MED-EL, Toray Medical, Sonova, Medtronic, Getinge (Maquet), William Demant, LivaNova (Sorin), Terumo, Hangzhou Nurotron, Syncardia, CorWave, Listent Medical, Evaheart, Open Bionics, OYMotion Technologies, Mobius Bionics

What are the Application segmentation covered in the Artificial Organs and Bionics Market report?

Ans: The Applications covered in the Artificial Organs and Bionics Market report are Commercialize, Clinical Research

What are the Type segmentation covered in the Artificial Organs and Bionics Market report?

Ans: The Types covered in the Artificial Organs and Bionics Market report are Artificial Kidney, Artificial Heart & Ventricular Assist Device, Cochlear Implant, Artificial Lung, Artificial Liver, Artificial Pancreas, Bionic Hands & Prosthetics, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Artificial Organs and Bionics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Artificial Kidney

1.2.3 Artificial Heart & Ventricular Assist Device

1.2.4 Cochlear Implant

1.2.5 Artificial Lung

1.2.6 Artificial Liver

1.2.7 Artificial Pancreas

1.2.8 Bionic Hands & Prosthetics

1.2.9 Others

1.3 Market by Application

1.3.1 Global Artificial Organs and Bionics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Commercialize

1.3.3 Clinical Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Artificial Organs and Bionics Market Perspective (2021–2032)

2.2 Global Artificial Organs and Bionics Growth Trends by Region

2.2.1 Global Artificial Organs and Bionics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Artificial Organs and Bionics Historic Market Size by Region (2021–2026)

2.2.3 Artificial Organs and Bionics Forecasted Market Size by Region (2027–2032)

2.3 Artificial Organs and Bionics Market Dynamics

2.3.1 Artificial Organs and Bionics Industry Trends

2.3.2 Artificial Organs and Bionics Market Drivers

2.3.3 Artificial Organs and Bionics Market Challenges

2.3.4 Artificial Organs and Bionics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Artificial Organs and Bionics Players by Revenue

3.1.1 Global Top Artificial Organs and Bionics Players by Revenue (2021–2026)

3.1.2 Global Artificial Organs and Bionics Revenue Market Share by Players (2021–2026)

3.2 Global Top Artificial Organs and Bionics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Artificial Organs and Bionics Revenue

3.4 Global Artificial Organs and Bionics Market Concentration Ratio

3.4.1 Global Artificial Organs and Bionics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Artificial Organs and Bionics Revenue in 2025

3.5 Global Key Players of Artificial Organs and Bionics Head Offices and Areas Served

3.6 Global Key Players of Artificial Organs and Bionics, Products and Applications

3.7 Global Key Players of Artificial Organs and Bionics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Artificial Organs and Bionics Breakdown Data by Type

4.1 Global Artificial Organs and Bionics Historic Market Size by Type (2021–2026)

4.2 Global Artificial Organs and Bionics Forecasted Market Size by Type (2027–2032)

5 Artificial Organs and Bionics Breakdown Data by Application

5.1 Global Artificial Organs and Bionics Historic Market Size by Application (2021–2026)

5.2 Global Artificial Organs and Bionics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Artificial Organs and Bionics Market Size (2021–2032)

6.2 North America Artificial Organs and Bionics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Artificial Organs and Bionics Market Size by Country (2021–2026)

6.4 North America Artificial Organs and Bionics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Artificial Organs and Bionics Market Size (2021–2032)

7.2 Europe Artificial Organs and Bionics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Artificial Organs and Bionics Market Size by Country (2021–2026)

7.4 Europe Artificial Organs and Bionics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Artificial Organs and Bionics Market Size (2021–2032)

8.2 Asia-Pacific Artificial Organs and Bionics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Artificial Organs and Bionics Market Size by Region (2021–2026)

8.4 Asia-Pacific Artificial Organs and Bionics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Artificial Organs and Bionics Market Size (2021–2032)

9.2 Latin America Artificial Organs and Bionics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Artificial Organs and Bionics Market Size by Country (2021–2026)

9.4 Latin America Artificial Organs and Bionics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Artificial Organs and Bionics Market Size (2021–2032)

10.2 Middle East & Africa Artificial Organs and Bionics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Artificial Organs and Bionics Market Size by Country (2021–2026)

10.4 Middle East & Africa Artificial Organs and Bionics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Fresenius Medical Care

11.1.1 Fresenius Medical Care Company Details

11.1.2 Fresenius Medical Care Business Overview

11.1.3 Fresenius Medical Care Artificial Organs and Bionics Introduction

11.1.4 Fresenius Medical Care Revenue in Artificial Organs and Bionics Business (2021–2026)

11.1.5 Fresenius Medical Care Recent Development

11.2 Cochlear

11.2.1 Cochlear Company Details

11.2.2 Cochlear Business Overview

11.2.3 Cochlear Artificial Organs and Bionics Introduction

11.2.4 Cochlear Revenue in Artificial Organs and Bionics Business (2021–2026)

11.2.5 Cochlear Recent Development

11.3 Abiomed

11.3.1 Abiomed Company Details

11.3.2 Abiomed Business Overview

11.3.3 Abiomed Artificial Organs and Bionics Introduction

11.3.4 Abiomed Revenue in Artificial Organs and Bionics Business (2021–2026)

11.3.5 Abiomed Recent Development

11.4 ABBOTT

11.4.1 ABBOTT Company Details

11.4.2 ABBOTT Business Overview

11.4.3 ABBOTT Artificial Organs and Bionics Introduction

11.4.4 ABBOTT Revenue in Artificial Organs and Bionics Business (2021–2026)

11.4.5 ABBOTT Recent Development

11.5 Baxter

11.5.1 Baxter Company Details

11.5.2 Baxter Business Overview

11.5.3 Baxter Artificial Organs and Bionics Introduction

11.5.4 Baxter Revenue in Artificial Organs and Bionics Business (2021–2026)

11.5.5 Baxter Recent Development

11.6 B.Braun

11.6.1 B.Braun Company Details

11.6.2 B.Braun Business Overview

11.6.3 B.Braun Artificial Organs and Bionics Introduction

11.6.4 B.Braun Revenue in Artificial Organs and Bionics Business (2021–2026)

11.6.5 B.Braun Recent Development

11.7 Asahi Kasei Corporation

11.7.1 Asahi Kasei Corporation Company Details

11.7.2 Asahi Kasei Corporation Business Overview

11.7.3 Asahi Kasei Corporation Artificial Organs and Bionics Introduction

11.7.4 Asahi Kasei Corporation Revenue in Artificial Organs and Bionics Business (2021–2026)

11.7.5 Asahi Kasei Corporation Recent Development

11.8 Nipro

11.8.1 Nipro Company Details

11.8.2 Nipro Business Overview

11.8.3 Nipro Artificial Organs and Bionics Introduction

11.8.4 Nipro Revenue in Artificial Organs and Bionics Business (2021–2026)

11.8.5 Nipro Recent Development

11.9 MED-EL

11.9.1 MED-EL Company Details

11.9.2 MED-EL Business Overview

11.9.3 MED-EL Artificial Organs and Bionics Introduction

11.9.4 MED-EL Revenue in Artificial Organs and Bionics Business (2021–2026)

11.9.5 MED-EL Recent Development

11.10 Toray Medical

11.10.1 Toray Medical Company Details

11.10.2 Toray Medical Business Overview

11.10.3 Toray Medical Artificial Organs and Bionics Introduction

11.10.4 Toray Medical Revenue in Artificial Organs and Bionics Business (2021–2026)

11.10.5 Toray Medical Recent Development

11.11 Sonova

11.11.1 Sonova Company Details

11.11.2 Sonova Business Overview

11.11.3 Sonova Artificial Organs and Bionics Introduction

11.11.4 Sonova Revenue in Artificial Organs and Bionics Business (2021–2026)

11.11.5 Sonova Recent Development

11.12 Medtronic

11.12.1 Medtronic Company Details

11.12.2 Medtronic Business Overview

11.12.3 Medtronic Artificial Organs and Bionics Introduction

11.12.4 Medtronic Revenue in Artificial Organs and Bionics Business (2021–2026)

11.12.5 Medtronic Recent Development

11.13 Getinge (Maquet)

11.13.1 Getinge (Maquet) Company Details

11.13.2 Getinge (Maquet) Business Overview

11.13.3 Getinge (Maquet) Artificial Organs and Bionics Introduction

11.13.4 Getinge (Maquet) Revenue in Artificial Organs and Bionics Business (2021–2026)

11.13.5 Getinge (Maquet) Recent Development

11.14 William Demant

11.14.1 William Demant Company Details

11.14.2 William Demant Business Overview

11.14.3 William Demant Artificial Organs and Bionics Introduction

11.14.4 William Demant Revenue in Artificial Organs and Bionics Business (2021–2026)

11.14.5 William Demant Recent Development

11.15 LivaNova (Sorin)

11.15.1 LivaNova (Sorin) Company Details

11.15.2 LivaNova (Sorin) Business Overview

11.15.3 LivaNova (Sorin) Artificial Organs and Bionics Introduction

11.15.4 LivaNova (Sorin) Revenue in Artificial Organs and Bionics Business (2021–2026)

11.15.5 LivaNova (Sorin) Recent Development

11.16 Terumo

11.16.1 Terumo Company Details

11.16.2 Terumo Business Overview

11.16.3 Terumo Artificial Organs and Bionics Introduction

11.16.4 Terumo Revenue in Artificial Organs and Bionics Business (2021–2026)

11.16.5 Terumo Recent Development

11.17 Hangzhou Nurotron

11.17.1 Hangzhou Nurotron Company Details

11.17.2 Hangzhou Nurotron Business Overview

11.17.3 Hangzhou Nurotron Artificial Organs and Bionics Introduction

11.17.4 Hangzhou Nurotron Revenue in Artificial Organs and Bionics Business (2021–2026)

11.17.5 Hangzhou Nurotron Recent Development

11.18 Syncardia

11.18.1 Syncardia Company Details

11.18.2 Syncardia Business Overview

11.18.3 Syncardia Artificial Organs and Bionics Introduction

11.18.4 Syncardia Revenue in Artificial Organs and Bionics Business (2021–2026)

11.18.5 Syncardia Recent Development

11.19 CorWave

11.19.1 CorWave Company Details

11.19.2 CorWave Business Overview

11.19.3 CorWave Artificial Organs and Bionics Introduction

11.19.4 CorWave Revenue in Artificial Organs and Bionics Business (2021–2026)

11.19.5 CorWave Recent Development

11.20 Listent Medical

11.20.1 Listent Medical Company Details

11.20.2 Listent Medical Business Overview

11.20.3 Listent Medical Artificial Organs and Bionics Introduction

11.20.4 Listent Medical Revenue in Artificial Organs and Bionics Business (2021–2026)

11.20.5 Listent Medical Recent Development

11.21 Evaheart

11.21.1 Evaheart Company Details

11.21.2 Evaheart Business Overview

11.21.3 Evaheart Artificial Organs and Bionics Introduction

11.21.4 Evaheart Revenue in Artificial Organs and Bionics Business (2021–2026)

11.21.5 Evaheart Recent Development

11.22 Open Bionics

11.22.1 Open Bionics Company Details

11.22.2 Open Bionics Business Overview

11.22.3 Open Bionics Artificial Organs and Bionics Introduction

11.22.4 Open Bionics Revenue in Artificial Organs and Bionics Business (2021–2026)

11.22.5 Open Bionics Recent Development

11.23 OYMotion Technologies

11.23.1 OYMotion Technologies Company Details

11.23.2 OYMotion Technologies Business Overview

11.23.3 OYMotion Technologies Artificial Organs and Bionics Introduction

11.23.4 OYMotion Technologies Revenue in Artificial Organs and Bionics Business (2021–2026)

11.23.5 OYMotion Technologies Recent Development

11.24 Mobius Bionics

11.24.1 Mobius Bionics Company Details

11.24.2 Mobius Bionics Business Overview

11.24.3 Mobius Bionics Artificial Organs and Bionics Introduction

11.24.4 Mobius Bionics Revenue in Artificial Organs and Bionics Business (2021–2026)

11.24.5 Mobius Bionics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sonova

Medtronic Inc

Cochlear Ltd

SynCardia

Fresenius Medical Care

Abiomed Inc

Abbott

Baxter

B. Braun

Asahi Kasei Corporation

Nipro

MED-EL

Toray Medical

Getinge (Maquet)

William Demant

LivaNova (Sorin)

Terumo

Hangzhou Nurotron

CorWave

Listent Medical

Evaheart

Open Bionics

OYMotion Technologies

Mobius Bionics

List of Tables

Table 1. Global Artificial Organs and Bionics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Artificial Kidney

Table 3. Key Players of Artificial Heart & Ventricular Assist Device

Table 4. Key Players of Cochlear Implant

Table 5. Key Players of Artificial Lung

Table 6. Key Players of Artificial Liver

Table 7. Key Players of Artificial Pancreas

Table 8. Key Players of Bionic Hands & Prosthetics

Table 9. Global Artificial Organs and Bionics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Artificial Organs and Bionics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 11. Global Artificial Organs and Bionics Market Size by Region (US$ Million), 2021–2026

Table 12. Global Artificial Organs and Bionics Market Share by Region (2021–2026)

Table 13. Global Artificial Organs and Bionics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 14. Global Artificial Organs and Bionics Market Share by Region (2027–2032)

Table 15. Artificial Organs and Bionics Market Trends

Table 16. Artificial Organs and Bionics Market Drivers

Table 17. Artificial Organs and Bionics Market Challenges

Table 18. Artificial Organs and Bionics Market Restraints

Table 19. Global Artificial Organs and Bionics Revenue by Players (US$ Million), 2021–2026

Table 20. Global Artificial Organs and Bionics Market Share by Players (2021–2026)

Table 21. Global Top Artificial Organs and Bionics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Artificial Organs and Bionics Revenue, 2025

Table 22. Ranking of Global Top Artificial Organs and Bionics Companies by Revenue (US$ Million) in 2025

Table 23. Global 5 Largest Players Market Share by Artificial Organs and Bionics Revenue (CR5 and HHI), 2021–2026

Table 24. Global Key Players of Artificial Organs and Bionics, Headquarters and Area Served

Table 25. Global Key Players of Artificial Organs and Bionics, Products and Applications

Table 26. Global Key Players of Artificial Organs and Bionics, Date of General Availability (GA)

Table 27. Mergers and Acquisitions, Expansion Plans

Table 28. Global Artificial Organs and Bionics Market Size by Type (US$ Million), 2021–2026

Table 29. Global Artificial Organs and Bionics Revenue Market Share by Type (2021–2026)

Table 30. Global Artificial Organs and Bionics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 31. Global Artificial Organs and Bionics Revenue Market Share by Type (2027–2032)

Table 32. Global Artificial Organs and Bionics Market Size by Application (US$ Million), 2021–2026

Table 33. Global Artificial Organs and Bionics Revenue Market Share by Application (2021–2026)

Table 34. Global Artificial Organs and Bionics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 35. Global Artificial Organs and Bionics Revenue Market Share by Application (2027–2032)

Table 36. North America Artificial Organs and Bionics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. North America Artificial Organs and Bionics Market Size by Country (US$ Million), 2021–2026

Table 38. North America Artificial Organs and Bionics Market Size by Country (US$ Million), 2027–2032

Table 39. Europe Artificial Organs and Bionics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. Europe Artificial Organs and Bionics Market Size by Country (US$ Million), 2021–2026

Table 41. Europe Artificial Organs and Bionics Market Size by Country (US$ Million), 2027–2032

Table 42. Asia-Pacific Artificial Organs and Bionics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 43. Asia-Pacific Artificial Organs and Bionics Market Size by Region (US$ Million), 2021–2026

Table 44. Asia-Pacific Artificial Organs and Bionics Market Size by Region (US$ Million), 2027–2032

Table 45. Latin America Artificial Organs and Bionics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Latin America Artificial Organs and Bionics Market Size by Country (US$ Million), 2021–2026

Table 47. Latin America Artificial Organs and Bionics Market Size by Country (US$ Million), 2027–2032

Table 48. Middle East & Africa Artificial Organs and Bionics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Middle East & Africa Artificial Organs and Bionics Market Size by Country (US$ Million), 2021–2026

Table 50. Middle East & Africa Artificial Organs and Bionics Market Size by Country (US$ Million), 2027–2032

Table 51. Fresenius Medical Care Company Details

Table 52. Fresenius Medical Care Business Overview

Table 53. Fresenius Medical Care Artificial Organs and Bionics Product

Table 54. Fresenius Medical Care Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 55. Fresenius Medical Care Recent Development

Table 56. Cochlear Company Details

Table 57. Cochlear Business Overview

Table 58. Cochlear Artificial Organs and Bionics Product

Table 59. Cochlear Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 60. Cochlear Recent Development

Table 61. Abiomed Company Details

Table 62. Abiomed Business Overview

Table 63. Abiomed Artificial Organs and Bionics Product

Table 64. Abiomed Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 65. Abiomed Recent Development

Table 66. ABBOTT Company Details

Table 67. ABBOTT Business Overview

Table 68. ABBOTT Artificial Organs and Bionics Product

Table 69. ABBOTT Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 70. ABBOTT Recent Development

Table 71. Baxter Company Details

Table 72. Baxter Business Overview

Table 73. Baxter Artificial Organs and Bionics Product

Table 74. Baxter Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 75. Baxter Recent Development

Table 76. B.Braun Company Details

Table 77. B.Braun Business Overview

Table 78. B.Braun Artificial Organs and Bionics Product

Table 79. B.Braun Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 80. B.Braun Recent Development

Table 81. Asahi Kasei Corporation Company Details

Table 82. Asahi Kasei Corporation Business Overview

Table 83. Asahi Kasei Corporation Artificial Organs and Bionics Product

Table 84. Asahi Kasei Corporation Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 85. Asahi Kasei Corporation Recent Development

Table 86. Nipro Company Details

Table 87. Nipro Business Overview

Table 88. Nipro Artificial Organs and Bionics Product

Table 89. Nipro Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 90. Nipro Recent Development

Table 91. MED-EL Company Details

Table 92. MED-EL Business Overview

Table 93. MED-EL Artificial Organs and Bionics Product

Table 94. MED-EL Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 95. MED-EL Recent Development

Table 96. Toray Medical Company Details

Table 97. Toray Medical Business Overview

Table 98. Toray Medical Artificial Organs and Bionics Product

Table 99. Toray Medical Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 100. Toray Medical Recent Development

Table 101. Sonova Company Details

Table 102. Sonova Business Overview

Table 103. Sonova Artificial Organs and Bionics Product

Table 104. Sonova Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 105. Sonova Recent Development

Table 106. Medtronic Company Details

Table 107. Medtronic Business Overview

Table 108. Medtronic Artificial Organs and Bionics Product

Table 109. Medtronic Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 110. Medtronic Recent Development

Table 111. Getinge (Maquet) Company Details

Table 112. Getinge (Maquet) Business Overview

Table 113. Getinge (Maquet) Artificial Organs and Bionics Product

Table 114. Getinge (Maquet) Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 115. Getinge (Maquet) Recent Development

Table 116. William Demant Company Details

Table 117. William Demant Business Overview

Table 118. William Demant Artificial Organs and Bionics Product

Table 119. William Demant Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 120. William Demant Recent Development

Table 121. LivaNova (Sorin) Company Details

Table 122. LivaNova (Sorin) Business Overview

Table 123. LivaNova (Sorin) Artificial Organs and Bionics Product

Table 124. LivaNova (Sorin) Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 125. LivaNova (Sorin) Recent Development

Table 126. Terumo Company Details

Table 127. Terumo Business Overview

Table 128. Terumo Artificial Organs and Bionics Product

Table 129. Terumo Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 130. Terumo Recent Development

Table 131. Hangzhou Nurotron Company Details

Table 132. Hangzhou Nurotron Business Overview

Table 133. Hangzhou Nurotron Artificial Organs and Bionics Product

Table 134. Hangzhou Nurotron Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 135. Hangzhou Nurotron Recent Development

Table 136. Syncardia Company Details

Table 137. Syncardia Business Overview

Table 138. Syncardia Artificial Organs and Bionics Product

Table 139. Syncardia Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 140. Syncardia Recent Development

Table 141. CorWave Company Details

Table 142. CorWave Business Overview

Table 143. CorWave Artificial Organs and Bionics Product

Table 144. CorWave Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 145. CorWave Recent Development

Table 146. Listent Medical Company Details

Table 147. Listent Medical Business Overview

Table 148. Listent Medical Artificial Organs and Bionics Product

Table 149. Listent Medical Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 150. Listent Medical Recent Development

Table 151. Evaheart Company Details

Table 152. Evaheart Business Overview

Table 153. Evaheart Artificial Organs and Bionics Product

Table 154. Evaheart Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 155. Evaheart Recent Development

Table 156. Open Bionics Company Details

Table 157. Open Bionics Business Overview

Table 158. Open Bionics Artificial Organs and Bionics Product

Table 159. Open Bionics Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 160. Open Bionics Recent Development

Table 161. OYMotion Technologies Company Details

Table 162. OYMotion Technologies Business Overview

Table 163. OYMotion Technologies Artificial Organs and Bionics Product

Table 164. OYMotion Technologies Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 165. OYMotion Technologies Recent Development

Table 166. Mobius Bionics Company Details

Table 167. Mobius Bionics Business Overview

Table 168. Mobius Bionics Artificial Organs and Bionics Product

Table 169. Mobius Bionics Revenue in Artificial Organs and Bionics Business (US$ Million), 2021–2026

Table 170. Mobius Bionics Recent Development

Table 171. Research Programs/Design for This Report

Table 172. Key Data Information from Secondary Sources

Table 173. Key Data Information from Primary Sources

Table 174. Authors List of This Report

List of Figures

Figure 1. Artificial Organs and Bionics Picture

Figure 2. Global Artificial Organs and Bionics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Artificial Organs and Bionics Market Share by Type: 2025 vs 2032

Figure 4. Artificial Kidney Features

Figure 5. Artificial Heart & Ventricular Assist Device Features

Figure 6. Cochlear Implant Features

Figure 7. Artificial Lung Features

Figure 8. Artificial Liver Features

Figure 9. Artificial Pancreas Features

Figure 10. Bionic Hands & Prosthetics Features

Figure 11. Others Features

Figure 12. Global Artificial Organs and Bionics Market Size by Application (US$ Million), 2021–2032

Figure 13. Global Artificial Organs and Bionics Market Share by Application: 2025 vs 2032

Figure 14. Commercialize Case Studies

Figure 15. Clinical Research Case Studies

Figure 16. Artificial Organs and Bionics Report Years Considered

Figure 17. Global Artificial Organs and Bionics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 18. Global Artificial Organs and Bionics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Artificial Organs and Bionics Market Share by Region: 2025 vs 2032

Figure 20. Global Artificial Organs and Bionics Market Share by Players in 2025

Figure 21. Global Artificial Organs and Bionics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. The Top 10 and 5 Players Market Share by Artificial Organs and Bionics Revenue in 2025

Figure 23. North America Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. North America Artificial Organs and Bionics Market Share by Country (2021–2032)

Figure 25. United States Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Canada Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe Artificial Organs and Bionics Market Share by Country (2021–2032)

Figure 29. Germany Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. France Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. U.K. Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Italy Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Russia Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Ireland Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific Artificial Organs and Bionics Market Share by Region (2021–2032)

Figure 37. China Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Japan Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. South Korea Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Southeast Asia Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. India Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Australia & New Zealand Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America Artificial Organs and Bionics Market Share by Country (2021–2032)

Figure 45. Mexico Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Brazil Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa Artificial Organs and Bionics Market Share by Country (2021–2032)

Figure 49. Israel Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Saudi Arabia Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. UAE Artificial Organs and Bionics Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Fresenius Medical Care Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 53. Cochlear Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 54. Abiomed Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 55. ABBOTT Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 56. Baxter Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 57. B.Braun Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 58. Asahi Kasei Corporation Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 59. Nipro Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 60. MED-EL Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 61. Toray Medical Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 62. Sonova Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 63. Medtronic Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 64. Getinge (Maquet) Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 65. William Demant Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 66. LivaNova (Sorin) Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 67. Terumo Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 68. Hangzhou Nurotron Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 69. Syncardia Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 70. CorWave Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 71. Listent Medical Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 72. Evaheart Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 73. Open Bionics Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 74. OYMotion Technologies Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 75. Mobius Bionics Revenue Growth Rate in Artificial Organs and Bionics Business (2021–2026)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Artificial Internal Organs Market Research Report 2024

Artificial Vital Organs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical Bionic Implant and Artificial Organs Market Research Report 2024

Global Artificial Vital Organs and Medical Bionics Market Insights Forecast to 2030

Global Biomedical Artificial Organ Market Research Report 2024

Global Artificial Organ Store Market Research Report 2024

Global Artificial Organ Bank Market Research Report 2024

Global Medical Bionic Implants Market Research Report 2025

Global Artificial Organ and Tissues Market Research Report 2025

Global Synthetic Bio implants Market Research Report 2024

Medical Bionics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artificial Heart Valve Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artificial Organs Market Research Report 2024

Global Limb Prosthetics Market Research Report 2024

Global Artificial Organs and Bionic Implants Market Research Report 2025

Global Plastic Prosthesis Market Research Report 2024

Artificial Implants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artificial Hip Replacement Prosthesis Market Research Report 2024

Global Bionic Prosthetic Limb Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions